Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

Q3 2021 patient services revenues of $316,329 represent a 235% increase over the previous quarter  Field…

Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica

TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF)…

Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market

TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF)…

Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

ATLANTA, Jan. 26, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field…

Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders

TORONTO, Jan. 07, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) (“Field…

Field Trip Health Ltd. Announces Closing of Bought Deal Financing

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (“Field Trip” or the “Company”) (CSE:…

Field Trip Health Ltd. Announces $15 Million Bought Deal Offering of Units

TORONTO, Dec. 9, 2020 /CNW/ – Field Trip Health Ltd. (“Field Trip” or the “Company“) (CSE: FTRP) (OTCBB: FTRPF),…

Field Trip Health Ltd. Reports Second Fiscal Quarter 2021 Financial Results, Announces Two New Field Trip Health Center Locations

Pre-clinical studies demonstrate potential of FT-104, its novel psychedelic molecule, as preferable option for psychedelic therapies,…

Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health

TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field Trip”), a…

Field Trip Health Ltd. Announces Expansion to The Netherlands and Launch of Proprietary Truffle Program

AMSTERDAM, Nov. 17, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field…

Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services

TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP) (“Field Trip”), one…

Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development

Results confirm that Field Trip’s novel psychedelic molecule is similar in potency to psilocybin but with…